World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
76
Citations
17092
World Ranking
1453
National Ranking
635

Robert K. Flamm publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Robert K. Flamm sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 433 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Robert K. Flamm D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Robert K. Flamm sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 76 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Robert K. Flamm is affiliated with Janssen in Belgium. Their research spans primarily the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with notable focus on Molecular Medicine, Infectious Diseases, Pharmacology, Epidemiology, and Clinical Biochemistry.

The scientist's work addresses several key topics, including:

  • Antibiotic Resistance in Bacteria
  • Antibiotics Pharmacokinetics and Efficacy
  • Antimicrobial Resistance in Staphylococcus
  • Bacterial Identification and Susceptibility Testing
  • Antibiotic Use and Resistance
  • Bacterial biofilms and quorum sensing
  • Cancer therapeutics and mechanisms

Frequent publication venues for their work include:

  • Diagnostic Microbiology and Infectious Disease
  • Open Forum Infectious Diseases
  • Antimicrobial Agents and Chemotherapy
  • Journal of Global Antimicrobial Resistance
  • Nature Communications

Robert K. Flamm has collaborated extensively with several coauthors, notably:

  • Michael D. Huband
  • Michael A. Pfaller
  • Rodrigo E. Mendes
  • Leonard R Duncan
  • Jennifer M Streit

Recent published papers include:

  • Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018, 2020, Antimicrobial Agents and Chemotherapy
  • Antimicrobial activity of manogepix, a first-in-class antifungal, and comparator agents tested against contemporary invasive fungal isolates from an international surveillance programme (2018-2019), 2021, Journal of Global Antimicrobial Resistance
  • Susceptibility trends of ceftolozane/tazobactam and comparators when tested against European Gram-negative bacterial surveillance isolates collected during 2012-18, 2020, Journal of Antimicrobial Chemotherapy
  • In Vitro Activity of KBP-7072, a Novel Third-Generation Tetracycline, against 531 Recent Geographically Diverse and Molecularly Characterized Acinetobacter baumannii Species Complex Isolates, 2020, Antimicrobial Agents and Chemotherapy
  • Surveillance of omadacycline activity tested against clinical isolates from the USA: report from the SENTRY Antimicrobial Surveillance Program, 2019, 2021, Journal of Global Antimicrobial Resistance

Best Publications

  • Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori.

    J Versalovic;D Shortridge;K Kibler;M V Griffy

  • Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: Results from the SENTRY Antimicrobial Surveillance Program, 2009–2012

    Helio S. Sader;David J. Farrell;Robert K. Flamm;Ronald N. Jones

  • Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011).

    Helio S. Sader;David J. Farrell;Robert K. Flamm;Ronald N. Jones

  • Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.

    J P Quinn;D Miyashiro;D Sahm;R Flamm

  • Antimicrobial Activity of Ceftolozane-Tazobactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2011-2012)

    David J. Farrell;Robert K. Flamm;Helio S. Sader;Ronald N. Jones

  • Introduction of pAM beta 1 into Listeria monocytogenes by conjugation and homology between native L. monocytogenes plasmids.

    R K Flamm;D J Hinrichs;M F Thomashow

  • Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995.

    Virginia D. Shortridge;Gary V. Doern;Angela B. Brueggemann;Jill M. Beyer

  • Emergence of Macrolide Resistance during Treatment of Pneumococcal Pneumonia

    Daniel M. Musher;Mark E. Dowell;Virginia D. Shortridge;Robert K. Flamm

  • Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae.

    Mariana Castanheira;Michael D. Huband;Rodrigo E. Mendes;Robert K. Flamm

  • Fluoroquinolone Resistance in Streptococcus pneumoniae in United States since 1994-1995

    Angela B. Brueggemann;Stacy L. Coffman;Paul Rhomberg;Holly Huynh

  • Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011–12)

    Helio S. Sader;David J. Farrell;Mariana Castanheira;Robert K. Flamm

  • Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002.

    Robert K. Flamm;Mellany K. Weaver;Clyde Thornsberry;Mark E. Jones

  • Novel mechanism of macrolide resistance in Streptococcus pneumoniae

    Virginia D. Shortridge;Robert K. Flamm;Nancy Ramer;Jill Beyer

  • Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Organisms Collected from U.S. Medical Centers in 2012

    Helio S. Sader;Mariana Castanheira;Robert K. Flamm;David J. Farrell

  • Antimicrobial susceptibility testing of Helicobacter pylori. Comparison of E-test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazole.

    Charles Y. Hachem;Jill E. Clarridge;Rita Reddy;Robert Flamm

  • Effect of the β-Lactamase Inhibitor Vaborbactam Combined with Meropenem against Serine Carbapenemase-Producing Enterobacteriaceae

    Mariana Castanheira;Paul R. Rhomberg;Robert K. Flamm;Ronald N. Jones

  • Novel Erythromycin Derivatives with Aryl Groups Tethered to the C-6 Position Are Potent Protein Synthesis Inhibitors and Active against Multidrug-Resistant Respiratory Pathogens

    Zhenkun Ma;Richard F. Clark;Antony Brazzale;Sanyi Wang

  • Characterization and Prevalence of MefA, MefE, and the Associated msr(D) Gene in Streptococcus pneumoniae Clinical Isolates

    Melissa M. Daly;Stella Doktor;Robert Flamm;Dee Shortridge

  • Affinity of doripenem and comparators to penicillin-binding proteins in Escherichia coli and Pseudomonas aeruginosa.

    Todd A. Davies;Wenchi Shang;Karen Bush;Robert K. Flamm

  • Ceftolozane/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012)

    David J. Farrell;Helio S. Sader;Robert K. Flamm;Ronald N. Jones

  • Update of dalbavancin spectrum and potency in the USA: report from the SENTRY Antimicrobial Surveillance Program (2011).

    Ronald N. Jones;Helio S. Sader;Robert K. Flamm

  • Pseudomonas aeruginosa Antimicrobial Susceptibility Results from Four Years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States

    Helio S. Sader;Michael D. Huband;Mariana Castanheira;Robert K. Flamm

Frequent Co-Authors

Helio S. Sader
Helio S. Sader JMI Laboratories
Ronald N. Jones
Ronald N. Jones JMI Laboratories
Rodrigo E. Mendes
Rodrigo E. Mendes JMI Laboratories
Mariana Castanheira
Mariana Castanheira JMI Laboratories
David J. Farrell
David J. Farrell University Hospital Southampton NHS Foundation Trust
Michael A. Pfaller
Michael A. Pfaller JMI Laboratories
Paul R. Rhomberg
Paul R. Rhomberg University of Iowa
Karen Bush
Karen Bush Indiana University
Sujata M. Bhavnani
Sujata M. Bhavnani University at Buffalo, State University of New York

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various healthcare and information technology careers. One promising pathway is becoming a functional medicine NP, where advanced knowledge of pathogens and immune responses is essential for personalized patient care.

For those interested in healthcare data and coding, pursuing a career as a certified professional coder provides opportunities to work closely with medical records, ensuring accuracy and compliance in billing processes.

Furthermore, the role of a health information management job description and salary highlights the growing demand for professionals who can manage and secure health data efficiently, bridging the gap between clinical and administrative functions.

To prepare for such roles, students can explore cahiim accredited health information management degree online programs, which offer flexible learning options and are recognized for their industry relevance and quality.

Best Scientists Citing Robert K. Flamm

Trending Scientists

Recently Published Articles